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Locomotor Response to a D1 Dopamine Receptor Agonist When
Glutamate Reuptake Is Inhibited
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The role of nucleus accumbens (NAcc) glutamate (GLU) and D1
dopamine (DA) receptor activation in the expression of locomo-
tor sensitization to amphetamine (AMPH) was investigated in
rats. Rats were preexposed to either AMPH or saline, and 2
weeks later their locomotion was assessed after a microinjec-
tion into the NAcc of the selective glutamate reuptake blocker
L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC) (10 nmol per
side), the D1-like DA receptor agonists SKF82958 (2.4 nmol per
side) and SKF38393 (3.1 nmol per side), the D2-like DA receptor
agonist quinelorane (3.1 nmol per side), or AMPH (6.8 nmol per
side). All compounds other than quinelorane increased locomo-
tion when infused into the NAcc. Only AMPH, however, pro-
duced enhanced locomotion in AMPH relative to saline-
preexposed rats. When additional rats were tested after NAcc
infusions of PDC together with either SKF82958 or quinelorane,
enhanced locomotion was observed in AMPH relative to saline-
preexposed rats after NAcc PDC 1 SKF82958. These results
suggest that in the NAcc, increased GLU neurotransmission
and activation of D1 DA receptors, neither of which is by itself
sufficient, together contribute to the expression of locomotor
sensitization by AMPH. They stress, with other findings, the
importance of GLU–DA interactions in the NAcc not only in the
generation of acute stimulant drug effects but in sensitized
responding to these drugs as well.
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Repeated exposure to psychomotor stimulants such as amphet-
amine (AMPH) leads to sensitization of their locomotor re-
sponse (Kalivas and Stewart, 1991). The nucleus accumbens
(NAcc) receives dopaminergic axonal projections from the ven-
tral tegmental area and has been implicated in the expression of
this effect (Perugini and Vezina, 1994a; Cador et al., 1995).
Ultrastructural anatomical studies of this site indicate that some
of the terminals of the descending glutamate (GLU) projections
from cortex and those of ascending dopamine (DA) mesence-
phalic projections come in close apposition to each other and
form synaptic contacts with the same intrinsic NAcc neurons
(Sesack and Pickel, 1990, 1992). Such a configuration provides the
structural basis for a possible interaction between GLU and DA
at the synaptic level in the NAcc.
A number of studies have shown that both DA and GLU
neurotransmission in the NAcc are altered by repeated exposure
to psychomotor stimulants. For example, previous exposure to
psychomotor stimulant drugs leads to enhanced stimulant-
induced DA overflow in the NAcc (Kalivas and Stewart, 1991;
Vezina, 1996), altered locomotor responding to NAcc infusions
of GLU receptor-specific ligands (Pierce et al., 1996; Kim and
Vezina, 1998), and enhanced inhibition of intrinsic NAcc neurons
by cocaine and D1 DA receptor but not D2 DA receptor agonists
(Henry and White, 1991, 1995; Wolf et al., 1994). Enhanced
cocaine-induced NAcc GLU overflow in stimulant-preexposed
animals has also been reported (Pierce et al., 1996; Reid and
Berger, 1996), although some have observed only increased as-
partate overflow (Robinson et al., 1997) and others have observed
no effect after amphetamine challenge (Xue et al., 1996; Wolf,
1998). GLU and DA also appear to interact to influence each
other’s synaptic release in the striatum and NAcc (Youngren et
al., 1993; Smith et al., 1995; Taber et al., 1996; Kalivas and Duffy,
1997; Reid et al., 1997; Segovia et al., 1997; West and Galloway,
1997; Dalia et al., 1998). Thus, although reflecting complex ef-
fects, these data collectively suggest that GLU and DA may
interact in a number of ways in the NAcc to influence the
expression of sensitization by psychomotor stimulants (Freed,
1994; Wolf, 1998; Vezina and Kim, 1999).
To further assess this possibility, the locomotor response of rats
previously exposed to amphetamine was assessed after infusion
into the NAcc of compounds known to increase extracellular
levels of GLU [L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC)]
or DA (AMPH) or to directly activate D1 (SKF38393,
SKF82958) or D2–3 DA (quinelorane) receptors. To specifically
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examine the contribution of GLU–DA interactions, the effects of
PDC and D1 or D2–3 DA receptor activation were examined
separately as well as in combination. Results indicate that in the
NAcc, increased levels of extracellular GLU and activation of D1
DA receptors, neither of which is by itself sufficient, together
contribute to the expression of locomotor sensitization by AMPH.
MATERIALS AND METHODS
Subjects. Male Sprague Dawley rats weighing 250–275 gm on arrival from
Harlan Sprague Dawley (Madison, WI) were housed individually in a 12
hr light /dark reverse cycle room with food and water available ad libitum.
They were anesthetized with ketamine (100 mg/kg, i.p.) followed by
xylazine (6 mg/kg, i.p.) 4–7 d after arrival, placed in a stereotaxic
instrument with the incisor bar positioned 5.0 mm above the interaural
line, and implanted with chronic bilateral guide cannulas (22 gauge;
Plastics One, Roanoke, VA) aimed at the NAcc (anteroposterior, 13.4;
lateral, 61.5; dorsoventral, 27.5 from bregma and skull) (Pellegrino et
al., 1979). Cannulas were angled at 10° to the vertical, positioned 1 mm
above the final injection site, and secured with dental acrylic cement
anchored to stainless steel screws fixed to the skull. After surgery, 28
gauge obturators were placed in the guide cannulas, and rats were
returned to their home cages for a 10 d recovery period. At the comple-
tion of the experiments, rats were anesthetized and perfused via intra-
cardiac infusion of saline and 10% formalin, brains were removed and
post-fixed in 10% formalin for 1 week, and coronal sections (40 mm) were
subsequently stained with cresyl violet for verification of injection can-
nula tip placements. All testing was conducted during the animals’ dark
cycle.
Drugs and intracranial microinjections. The competitive inhibitor of
GLU reuptake, PDC (10.0 nmol per side), the D1 DA receptor agonists
(6)-SKF82958 HBr [2.4 nmol (1 mg) per side] and R(1)-SKF38393
diHCl [3.1 nmol (1 mg) per side], the D2–3 DA receptor agonist quinelo-
rane diHCl (Sautel et al., 1995) [3.1 nmol (1 mg) per side], the D1 DA
receptor antagonist R(1)-SCH23390 HCl [0.8 nmol (1 mg) per side], and
the D2 DA receptor antagonist S(2)eticlopride HCl [2.7 nmol (1 mg) per
side] were obtained from Research Biochemicals Internationals (Natick,
MA). All were dissolved in water, and small aliquots stored at 280°C.
Immediately before use, frozen aliquots of the drugs were diluted in
sterile 0.9% saline and prepared either separately or as a mixture.
S(1)-AMPH sulfate (National Institute on Drug Abuse, Rockville, MD)
was dissolved in sterile 0.9% saline and injected intraperitoneally (pre-
exposure; 1.0 mg/kg) and into the NAcc [test for sensitization; 6.8 nmol
(2.5 mg) per side). All doses refer to the weight of the salt and are based
on previous reports of the locomotor effects of PDC (Kim and Vezina,
1999) and DA receptor agonists and antagonists (Vezina et al., 1991;
Meyer et al., 1993; Vezina, 1996; Swanson et al., 1997). Solution pHs
ranged from 5.5 to 7.0, values well within the limits of rat brain buffering
power (Chesler, 1990). Bilateral intracranial microinjections into the
NAcc were made in the freely moving rat. Injection cannulas (28 gauge)
connected to 1 ml syringes (Hamilton, Reno, NV) via PE-20 tubing were
inserted to a depth of 1 mm below the guide cannula tips. Injections were
made in a volume of 0.5 ml per side over 30 sec. Sixty seconds later, the
injection cannulas were withdrawn, the obturators were replaced, and
rats were placed immediately in the activity boxes.
Locomotor activity. A bank of 12 activity boxes was used to measure
locomotor activity. Each box (22 3 43 3 33 cm) was constructed of
opaque plastic (rear and two side walls), a Plexiglas front-hinged door,
and a tubular stainless steel ceiling and floor. Two photocells, positioned
3.5 cm above the floor and spaced evenly along the longitudinal axis of
each box, estimated horizontal locomotion. Two additional photocells,
positioned on the side walls 16.5 cm above the floor and 5 cm from the
front and back walls, estimated rearing. Separate interruptions of pho-
tocell beams were detected and recorded via an electrical interface by a
computer situated in an adjacent room. The activity boxes were kept in
a room lighted dimly with red light.
Design and procedure. The sensitization experiments consisted of two
phases: a drug preexposure phase and a test for sensitization. During the
drug preexposure phase, different groups of rats were administered
either saline (1 ml/kg, i.p.) or AMPH (1 mg/kg, i.p.) on four occasions,
one injection every 3–4 d. Immediately after the first and fourth injec-
tions, rats were placed in the activity boxes for 2 hr. They were returned
to their home cages after the second and third injections. On the test for
sensitization, 2 weeks after the last preexposure injection, animals were
administered their designated infusion bilaterally into the NAcc and
placed immediately in the activity boxes for 2 hr. In all cases, rats were
habituated to the activity boxes for 1 hr before the NAcc infusion.
In a separate control experiment designed to assess the D1 DA recep-
tor specificity of SKF82958, rats in different groups were first habituated
to the activity boxes for 1 hr after which they were administered their
respective NAcc infusion and returned to the activity boxes for an
additional 2 hr.
The data were analyzed with two-way and three-way between–within
ANOVA. In the former case, NAcc infusion was the between factor and
time the within factor (see Table 1). In the latter case, preexposure
condition and NAcc infusion were the between factors and time the
within factor (see Figs. 1, 2). Post hoc Scheffe´ comparisons were made
according to Kirk (1968).
RESULTS
Histology
Only rats with injection cannula tips located bilaterally in the
NAcc were included in the data analyses. Of the total of 145 rats
tested, 6 were excluded for failing to meet this criterion. No
neuronal damage was observed other than that produced by the
insertion of the cannulas.
Previous exposure to AMPH leads to enhanced
locomotor responding to NAcc AMPH but not to NAcc
PDC, SKF82958, SKF38393, or quinelorane
Figure 1 shows the locomotor activity counts obtained in rats
preexposed 2 weeks earlier to AMPH or saline and tested after
NAcc infusion of either PDC, SKF82958, SKF38393, quinelo-
rane, or AMPH. As expected, all test compounds other than
Figure 1. Locomotion (A) and rearing (B) observed after microinjection
of PDC, SKF82958, SKF38393, quinelorane, or AMPH into the NAcc 2
weeks after preexposure to amphetamine or saline IP. Only NAcc AMPH
produced enhanced locomotor-activating effects in AMPH relative to
saline-preexposed rats. Data are shown as group mean (1SEM) locomo-
tion and rearing counts observed during the first and second hour of a 2
hr test. Numbers at the base of the different columns indicate n per group.
*p , 0.05, ***p , 0.001; significantly more counts in AMPH relative to
saline-preexposed animals at the indicated time as determined by post hoc
Scheffe´ comparisons after ANOVA.
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quinelorane increased locomotion and rearing when compared
with NAcc saline ( p , 0.05–0.001). These locomotor effects were
mostly restricted to the first hour of testing, although in the case
of SKF38393, increased locomotor activity continued into the
second hour. Quinelorane decreased locomotor activity some-
what throughout testing, although this effect did not achieve
statistical significance (cf. Swanson et al., 1997). Of the com-
pounds tested, however, only NAcc AMPH [in agreement with
Paulson and Robinson (1991)] produced enhanced locomotion
and rearing in AMPH compared with saline-preexposed rats
( p , 0.05–0.001). The remaining compounds increased locomo-
tion and rearing but to a similar extent in the two preexposure
conditions. The above p values were determined by post hoc
Scheffe´ comparisons after an ANOVA that found multiple signif-
icant effects, including effects of NAcc infusion [F(5,62) 5 29.9 and
27.1; p , 0.001] as well as significant NAcc infusion 3 preexpo-
sure condition [F(5,62) 5 6.6 and 6.4; p , 0.001], and NAcc
infusion 3 preexposure condition 3 time interactions [F(5,62) 5
3.4 and 6.7; p , 0.01–0.001] for locomotion and rearing,
respectively.
Previous exposure to AMPH leads to enhanced
locomotor responding to NAcc SKF82958 in the
presence of PDC
When challenged with NAcc PDC 1 SKF82958, rats preexposed
2 weeks earlier to AMPH showed levels of locomotion and
rearing that were significantly higher than those displayed by
saline-preexposed rats (Fig. 2A,B). The ANOVA conducted on
these data again showed multiple significant effects, including
effects of NAcc infusion [F(1,21) 5 7.1 and 9.5; p , 0.05–0.01] as
well as significant NAcc infusion 3 preexposure condition 3 time
interactions [F(7,147) 5 2.0 and 7.2; p , 0.5–0.001], for locomotion
and rearing, respectively. Post hoc comparisons revealed that the
enhanced locomotor effects of NAcc PDC 1 SKF82958 were
restricted to the first hour of testing ( p , 0.5–0.001) (Fig. 2A,B,
insets). No significant differences were detected between AMPH
and saline-preexposed rats at any time points when these were
challenged with PDC 1 quinelorane. In saline-preexposed rats,
NAcc PDC 1 SKF82958 elicited significantly more locomotion
and rearing in the first 15 min of testing than NAcc PDC 1
quinelorane ( p , 0.05–0.001).
Figure 2. D1 , but not D2–3, DA receptor activation in the NAcc produces enhanced locomotor responding when GLU reuptake is locally inhibited in
AMPH preexposed rats. Data are shown as group mean (6 SEM) locomotion (A) and rearing (B) activity counts obtained after the sensitization test
injection. Insets show total counts obtained in the first hour of testing. Numbers of rats in each group are indicated at the base of the different columns.
1 denotes mixture injections. The remaining symbols indicate significant differences as revealed by post hoc Scheffe´ comparisons after ANOVA. *p ,
0.05, ***p , 0.001; AMPH compared with saline-preexposed rats tested with PDC 1 SKF82958. C, Location of the microinjection cannula tips in the
NAcc of rats included in the data analyses. The line drawings are from Paxinos and Watson (1986). Numbers to the right indicate millimeters from
bregma. Symbols represent the different groups: E, saline (preexposure, i.p.)—PDC 1 SKF82958 (test, intra-NAcc); F, AMPH—PDC 1 SKF82958; M,
saline—PDC 1 quinelorane; f, AMPH—PDC 1 quinelorane.
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The location of injection cannula tips in the NAcc of the rats
that were included in this experiment are illustrated in Figure 2C.
Locomotor activating effects of SKF82958 are D1 DA
receptor specific
The D1 DA receptor specificity of SKF82958 was assessed di-
rectly in a separate control experiment. Table 1 shows that the
locomotor-activating effects of SKF82958 were blocked when
coinjected into the NAcc with the D1 DA receptor-specific an-
tagonist SCH23390 (0.8 nmol per side) but spared when coin-
jected with the D2 DA receptor-specific antagonist eticlopride
(2.7 nmol per side). Thus, under the present conditions,
SKF82958 appeared to produce its effects on locomotion in a D1
DA receptor-dependent manner.
DISCUSSION
The present results demonstrate that in a manner similar to
AMPH, simultaneous activation of D1 DA receptors and block-
ade of GLU reuptake in the NAcc produces enhanced locomotor
responding in AMPH compared with saline-preexposed rats.
These results, together with the additional finding that these
manipulations failed to produce sensitized responding when ad-
ministered by themselves, clearly illustrate the importance of
GLU–DA interactions in the NAcc in the expression of AMPH-
induced locomotor sensitization.
It has been shown that NAcc infusion of the AMPA receptor
agonist AMPA enhances locomotor responding in cocaine-
preexposed rats, relative to saline-preexposed rats, and that the
AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-
2,3-dione in the NAcc abolishes sensitized responding to systemic
cocaine challenge (Pierce et al., 1996). This finding of increased
AMPA receptor responsiveness in cocaine-sensitized rats is con-
sistent with others showing a significant increase in NAcc GluR1
levels in cocaine-preexposed rats (Churchill et al., 1999), although
evidence for decreased responsiveness has been suggested by
electrophysiological studies (White et al., 1995; Wolf, 1998). In
contrast, the metabotropic GLU receptor (mGluR) antagonist
(RS)-a-methyl-4-carboxyphenylglycine, but not the mGluR ago-
nist 1-aminocyclopentane-trans-1,3-dicarboxylic acid, was found
to produce enhanced locomotor activity when microinjected into
the NAcc in AMPH compared with saline-preexposed rats (Kim
and Vezina, 1998). These findings indicate that NAcc GLU may
differentially impact locomotor activity in stimulant-preexposed
animals depending on the GLU receptor subtype activated. Thus,
the present results showing that increasing extracellular levels of
GLU with NAcc PDC (Griffiths et al., 1994) increased locomo-
tion equally in AMPH- and saline-preexposed rats may reflect the
net outcome of simultaneously activating multiple subtypes of
GLU receptors in this site.
The lack of sensitized locomotor responding to NAcc infusions
of D1 DA receptor agonists in AMPH-preexposed rats is consis-
tent with previous reports (Perugini and Vezina, 1994b; Pierce
and Kalivas, 1995). In apparent contrast to these results, it has
been shown in electrophysiological experiments that previous
exposure to psychomotor stimulant drugs leads to enhanced D1
(but not D2) DA receptor sensitivity in the NAcc (Henry and
White, 1991; Wolf et al., 1994) that may persistently accompany
the expression of behavioral sensitization (Henry and White,
1995). It must be noted, however, that in these experiments, D1
DA receptor supersensitivity was always observed in the presence
of iontophoretically applied GLU. Importantly, when experi-
ments were conducted in the absence of GLU and the ability of
SKF38393 to inhibit Na1 current was assessed using whole-cell
patch-clamp recordings in NAcc neurons dissociated from
cocaine- and saline-preexposed rats, enhanced D1 DA receptor
sensitivity was not observed (Zhang et al., 1998). Interestingly,
the direction of the modulation by DA of NAcc medium spiny
neuron firing has also been shown to be dependent on the
glutamatergic tone imposed on these cells by descending GLU
projections from cortex (Gonon and Sundstrom, 1996). Whatever
the manner in which these effects impact the firing of intrinsic
NAcc output neurons and, as a consequence, the generation of
locomotor activity, it is intriguing that they very much parallel the
present findings showing that enhanced locomotor responding to
D1 DA receptor activation was observed only in the presence of
GLU reuptake block in rats previously exposed to AMPH.
Elevating extracellular levels of GLU either directly or indi-
rectly with PDC has been reported to increase extracellular levels
of DA in both the striatum and the NAcc (Youngren et al., 1993;
Taber et al., 1996; Segovia et al., 1997; West and Galloway, 1997),
whereas NAcc DA agonists and psychomotor stimulants increase
GLU levels in this site (Smith et al., 1995; Kalivas and Duffy,
1997; Reid et al., 1997; Dalia et al., 1998; Wolf, 1998). However,
it remains to be determined whether GLU or a D1 DA receptor
agonist is also capable of evoking enhanced increase of DA or
GLU overflow, respectively, in sensitized animals. Previous ex-
posure to psychomotor stimulant drugs has been shown to lead to
enhanced cocaine-induced overflow of GLU and DA as well as
aspartate in the NAcc (Pierce et al., 1996; Reid and Berger, 1996;
Table 1. The increased locomotion and rearing produced acutely by SKF 82958 in the NAcc is D1 DA
receptor dependent
Acute NAcc microinjection
Locomotion Rearing
1st hr 2nd hr 1st hr 2nd hr
SKF82958 (12) 404.3 6 41.4*** 182.8 6 29.5 177.5 6 24.8*** 65.3 6 13.7
SAL (9) 303.0 6 37.8 74.0 6 24.6 84.0 6 13.9 26.0 6 5.3
SKF82958 1 SCH23390 (6) 287.3 6 33.9 109.3 6 14.6 108.2 6 28.0 34.5 6 9.7
SKF82958 1 eticlopride (5) 381.0 6 33.1*** 138.0 6 17.3 188.6 6 50.1*** 71.0 6 22.4
SCH23390 (5) 255.8 6 10.8 129.4 6 23.1 130.6 6 16.8 40.8 6 12.4
Eticlopride (7) 199.0 6 28.7 99.7 6 15.1 89.6 6 10.2 32.3 6 8.0
Data are shown as group mean (6SEM) locomotion and rearing counts during the first and second hour of a 2 hr test.
Numbers in parentheses indicate n/group. ***p , 0.001, significantly more counts by SKF82958 and SKF82958 1 eticlopride
rats relative to all remaining animals at the indicated times as determined by post hoc Scheffe´ comparisons after two-way
between–within ANOVA. 1 denotes mixture injections.
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Xue et al., 1996; Robinson et al., 1997). These findings reflect the
ability of such drugs to simultaneously recruit both of these
hyper-responsive neurotransmitter pathways, and as a conse-
quence, this may lead to the generation of sensitized locomotor
activity. How these events are integrated postsynaptically in the
NAcc to produce sensitized locomotor responding remains un-
known, however. It is possible that such events may initially take
the form of extrasynaptic or volumetric type interactions similar
to what has been suggested in the striatum (Lannes and
Micheletti, 1994), considering the fact that no direct synapses
have been found between GLU and DA terminals, despite their
close apposition to each other as they form synapses with intrinsic
NAcc cells (Sesack and Pickel, 1990, 1992). Then, enhanced
glutamatergic input to the NAcc, by acting at GLU receptors in
this site, may regulate incoming dopaminergic signals (or vice
versa), possibly by acting on second messenger pathways with
which they are coupled and thereby influence the generation of
locomotor activity (Vezina and Kim, 1999).
Interactions between PDC and D2 DA receptor activation were
not observed in the present study, suggesting in a manner con-
sistent with previous studies (Henry and White, 1991; Wolf et al.,
1994) a more important role for enhanced NAcc D1 DA receptor
sensitivity in the expression of sensitization by psychomotor stim-
ulants. Quinelorane has been shown to inhibit AMPH-induced
locomotion by activating postsynaptic D2–3 DA receptors (Thorn
et al., 1997). Similar, although relatively shorter, effects may have
been produced in the present study with PDC in that in the initial
15 min of testing, animals administered PDC 1 quinelorane
(regardless of preexposure condition) exhibited less locomotor
activity than saline-preexposed rats administered PDC 1
SKF82958. It was recently reported that SKF82958 (and possibly
other benzazepines including SKF38393) can block potassium
channels (Nisenbaum et al., 1998) and that SKF82958, in partic-
ular, may possess D2 DA autoreceptor agonist properties (Ruskin
et al., 1998). Although these studies used relatively high agonist
concentrations, it was also difficult to compare them with those
used in the present experiments because different routes of ad-
ministration were used. It is clear from the control data shown in
Table 1, however, that under the present conditions, the
locomotor-activating effects of SKF82958 were D1 DA receptor
specific.
In summary, the present results demonstrate that sensitized
locomotor activity in AMPH-preexposed rats can be elicited by
coinfusion into the NAcc of PDC together with a D1 DA receptor
agonist. The additional finding that neither of these substances
administered alone is capable of producing this effect clearly
illustrates the importance of interactions between GLU and D1
DA receptors in the NAcc in the expression of locomotor sensi-
tization by AMPH.
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